Corteva, Inc.

(New York Stock Exchange)
Bullish +62

Assenagon Asset Management S.A. Decreases Stock Holdings in Corteva ...

πŸ“‰ Assenagon Asset Management S.A. decreased its Corteva holdings by 44.7% in Q1, selling over 400,000 shares.

πŸ’° The remaining Assenagon stake is valued at $41,815,000 as of the latest SEC filing.

πŸ“ˆ Multiple wealth management firms opened new positions totaling approximately $139,000 in Q3 and Q4.

🏦 Institutional investors collectively own 81.54% of Corteva's outstanding stock.

πŸ“Š CTVA stock is trading at $81.51 with a market cap of $54.52 billion.

πŸ’΅ The company recently paid a $0.18 per share dividend, annualizing to a 0.9% yield.

πŸ”­ Barclays raised its price target from $84.00 to $91.00 with an 'overweight' rating.

🎯 Goldman Sachs increased its target to $96.00 and maintains a 'buy' rating.

πŸ“‰ The stock trades at a P/E ratio of 47.95 with a beta of 0.57.

🌱 Corteva focuses on seed genetics, crop protection chemistries, and digital tools for farmers.

Bullish Signals
  • Major analysts including Barclays, Mizuho, Morgan Stanley, and Goldman Sachs have recently raised their price targets for Corteva, signaling confidence in future performance.
  • The stock is trading near its 52-week high of $85.63, suggesting strong recent market momentum.
  • Institutional ownership remains robust at 81.54%, indicating sustained interest from large investors despite individual position adjustments.
  • Corteva maintains a healthy balance sheet with a current ratio of 1.47 and a low debt-to-equity ratio of 0.07.
Risk Factors
  • A significant institutional investor, Assenagon Asset Management S.A., reduced its position by nearly half in the first quarter.
  • The stock trades at a high P/E ratio of 47.95, which may suggest elevated valuation relative to earnings.
Full Analysis
Assenagon Asset Management S.A. significantly reduced its position in Corteva, Inc. (NYSE:CTVA) by 44.7% during the first quarter, selling 403,529 shares to hold a remaining stake of 499,517 shares valued at approximately $41.8 million according to recent SEC filings. Despite this notable decrease by one major institutional holder, several other wealth management firms and hedge funds established new positions in the stock during the third and fourth quarters, with stakes ranging from roughly $25,000 to $30,000 each, indicating continued institutional interest. Analyst sentiment remains broadly positive with major financial institutions including Barclays, Mizuho, Morgan Stanley, and Goldman Sachs recently raising their price targets for Corteva between $84.00 and $96.00, while maintaining 'overweight' or 'buy' ratings. Corteva continues to operate as an independent global agriculture company with a market capitalization of $54.52 billion, trading near its 52-week high, and recently paid a quarterly dividend yielding 0.9% to shareholders of record.